Clinical Insights

Targeted Radiofrequency Ablation of Painful Spinal Metastases in Myeloma

12/26/2016

Duncan Street, MRCP (UK)¹; John F. Morlese, FRCR¹; Amit Shah, BSc, FRCR¹; Steven Morgan, FRCR²; Mamta Garg, MD, FRCP, FRCPath (Hematology)¹; Winston J. Rennie, MSc, FRCR^1,3

From the ¹Leicester Royal Infirmary, Leicester, United Kingdom, ²Southmead Hospital Bristol, Bristol, United Kingdom, and ³University of Loughborough, Loughborough, United Kingdom.

Duncan Street, MRCP (UK)1; John F. Mo...

Abstract: Metastasis to bone occurs in the majority of cancers, with the thoracolumbar spine being the most common site of metastasis. Metastatic disease to the spine is a common clinical situation that causes significant morbidity, with...

Abstract: Metastasis to bone...

12/26/2016

IO Learning

Clinical Insights

An Interventional Oncology Research Roundup

12/26/2016

See below for summaries from selected papers published in 2016 on various interventional oncology therapies. Study Finds No Difference Between Drug-Eluting vs Bland Microspheres for Liver Tumors This single-center randomized trial aimed to...

See below for summaries from...

12/26/2016

IO Learning

Clinical Insights

Nanocomposite Carriers for Transarterial Chemoembolization of Liver Cancer

11/17/2016

Dong-Hyun Kim, PhD^1,2*; Andrew C. Larson, PhD^1,2,3,4,5

From the ¹Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, ²Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois,³Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, ⁴Department of Electrical Engineering and Computer Science, Evanston, Illinois, and ⁵International Institute of Nanotechnology (IIN), Northwestern University, Evanston, Illinois.

Dong-Hyun Kim, PhD1,2*; Andrew C. Lar...

Abstract: The efficacy of conventional transarterial chemoembolization (TACE) approaches in liver cancer treatment is limited by the lack of effective drug carriers and/or the inability to monitor drug delivery to the targeted tumor tissues....

Abstract: The efficacy of...

11/17/2016

IO Learning

Clinical Insights

This Year in Interventional Oncology

11/01/2016

Read below for summaries of some of the most important news from 2016 about interventional oncology therapies and devices. University of Miami Creates First Department of Interventional Radiology The University of Miami has created a...

Read below for summaries of some...

11/01/2016

IO Learning

Clinical Insights

Intraesophageal Hyperthermia-Enhanced Direct Tumor Chemotherapy: An Interview With Feng Zhang, MD, PhD

10/30/2016

Interview by Jennifer Ford

IO360: How does intraesophageal chemotherapy work? How do you perform the procedure, and with what devices?Zhang: Image-guided minimally invasive interventional oncology techniques enable delivery of high doses of chemotherapeutics into...

IO360: How does intraesophageal...

10/30/2016

IO Learning

Clinical Insights

Transarterial Embolization of Hepatocellular Carcinoma in Hepatitis B Cirrhosis Using Transulnar Approach

10/13/2016

Andrew Kesselman, MD; Vincent Gallo, MD; Michael Herskowitz, MD; James Walsh, MD

From the Radiology Department of SUNY Downstate Medical Center, Brooklyn, New York.

Andrew Kesselman, MD; Vincent Gallo, ...

Abstract: Recent publications have demonstrated that transradial access is safe and well tolerated in a heterogeneous patient population across a wide range of peripheral vascular interventions. Both the transradial and transulnar approach...

Abstract: Recent publications...

10/13/2016

IO Learning

Clinical Insights

Neoadjuvant Transarterial Chemoembolization of Cirrhotomimetic Hepatocellular Carcinoma: An Interview With Peiman Habibollahi, MD

10/13/2016

Interview by Jennifer Ford

Peiman Habibollahi, MD, is a resident of radiology at the Hospital of the University of Pennsylvania in Philadelphia. At the 2016 annual scientific meeting of the Society for Interventional Radiology (SIR), he presented outcomes from a study...

Peiman Habibollahi, MD, is a...

10/13/2016

IO Learning

Clinical Insights

Percutaneous Thermal Ablation for Small Renal Tumors: An Interview With Adam D. Talenfeld, MD

09/15/2016

Interview by Jennifer Ford

Adam D. Talenfeld, MD, is an attending physician at Weill Cornell Medical Center, New York Presbyterian Hospital in New York and a member of the Society of Interventional Radiology Foundation Quality and Outcomes Division’s Comparative...

Adam D. Talenfeld, MD, is an...

09/15/2016

IO Learning

Clinical Insights

Optimizing Reimbursement for Radioembolization: The Importance of Adequate Documentation

08/25/2016

Rishi Chopra, MS¹; Jason C. Hoffmann, MD¹; Amanjit S. Baadh, MD²

From¹Winthrop University Hospital, Department of Radiology, Mineola, New York, and ²Rush University Medical Center, Department of Interventional Radiology, Chicago, Illinois.

Rishi Chopra, MS1; Jason C. Hoffmann,...

ABSTRACT: Purpose: This article aims to review radioembolization-specific coding guidelines so that interventional radiologists can develop a better understanding of what documentation is essential in their reports, leading to appropriate...

ABSTRACT: Purpose: This article...

08/25/2016

IO Learning

Clinical Insights

A Study of Thrombosis After Microwave Ablation of Liver Tumors: An Interview With Alexander Sheu, MD, and Gloria Hwang, MD

08/16/2016

Interview by Jennifer Ford

Alexander Sheu, MD, and Gloria Hwang, MD, from Stanford University studied the effect of microwave ablation on portal vein and hepatic vein thrombosis in hepatocellular carcinoma and liver metastases. They spoke with Interventional Oncology...

Alexander Sheu, MD, and Gloria...

08/16/2016

IO Learning

IO Learning Newsletter

News

Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma

07/29/2024

Allison Casey ;

According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.

According to a phase 3 trial,...

07/29/2024

Oncology

News

Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases

07/18/2024

Allison Casey ;

According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.

According to the phase 3...

07/18/2024

IO Learning

News

Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma

07/17/2024

Allison Casey ;

According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...

According to a post-hoc,...

07/17/2024

IO Learning

News

Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter

07/09/2024

Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...

Transit Scientific Press...

07/09/2024

Vascular Disease Management

Imaging Systems

University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients

05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...

The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.

The new alliance will enhance...

05/08/2024

Cath Lab Digest

News

Histotripsy Treatment for Primary and Metastatic Liver Tumors

04/25/2024

Allison Casey

At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.

At the 2023 CIRSE Annual...

04/25/2024

IO Learning

News

First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow

04/24/2024

Syntervention Press Release

Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...

Rocky Mount, North Carolina,...

04/24/2024

EP Lab Digest

News

Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses

11/30/2023

Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...

Salt Lake City (UT) – Fluidx...

11/30/2023

Vascular Disease Management

News

Radiation Therapy May Be Potential Heart Failure Treatment

11/28/2023

Julia Evangelou Strait

Julia Evangelou Strait

The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.

The study suggests that low-dose...

11/28/2023

Cath Lab Digest

News

Canon Medical Introduces Alphenix Sky 12 HD Interventional System

09/12/2023

Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...

Tustin, CA (12 September 2023) —...

09/12/2023

IO Learning

Clinical Insights

Subscribe

News

Specialties

Events

Year Round Education

HMP Global Products